Health
Tiny antibody component highly effective against SARS-COV-2 in animal studies – Medical Xpress
University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19. This antibody component, which is 10 times smaller…
University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19. This antibody component, which is 10 times smaller than a full-sized antibody, has been used to construct a drugknown as Ab8for potential use as a therapeutic and prophylactic against SARS-CoV-2.
The researchers report today in the journal Cell that Ab8 is highly effective in preventing an…
-
Business17 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News14 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business18 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business14 hours ago1 ASX dividend stock down 43% I’d buy right now